{"id":26424,"date":"2022-09-14T06:32:02","date_gmt":"2022-09-14T06:32:02","guid":{"rendered":"https:\/\/cardiacinstitute.bg\/?page_id=26424"},"modified":"2022-09-14T06:40:11","modified_gmt":"2022-09-14T06:40:11","slug":"peripheral-neuropathy","status":"publish","type":"page","link":"https:\/\/cardiacinstitute.bg\/ro\/for-patients\/peripheral-neuropathy\/","title":{"rendered":"Neuropatie periferica"},"content":{"rendered":"
[vc_row][vc_column][mk_fancy_title tag_name=”h4″ color=”#1e73be” size=”36″ force_font_size=”true” size_phone=”30″ txt_transform=”uppercase” font_family=”Open+Sans” font_type=”google” animation=”top-to-bottom”]\n

Neuropatie periferica<\/p>\n[\/mk_fancy_title][mk_padding_divider][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1663137609630{margin-bottom: 0px !important;}”]Spitalul pentru Inima si Creier are disponibile in clinica sa de neurologie echipamente pentru diagnosticarea precoce a polineuropatiei diabetice periferice<\/strong><\/p>\n

\u2713 Conform studiilor clinice, \u201eNeuropatia autonoma cardiovasculara este observata la aproximativ 17% dintre pacien\u021bii cu diabet de tip 1 \u0219i la 22% dintre cei cu diabet de tip 2\u201d.
\n\u2713 \u201eDin pacientii cu disfunctie autonoma simptomatica, 25% p\u00e2n\u0103 la 50% mor in decurs de 1 p\u00e2na la 5 ani de la diagnostic.\u201d
\n\u2713 \u201eAnamneza si examenul fizic sunt ineficiente pentru diagnosticul precoce al neuropatiei autonome cardiovasculare (CAN), de aceea sunt necesare teste neinvazive.\u201d
\n\u2713 \u201eDepistarea polineuropatiei diabetice trebuie efectuata imediat dupa diagnosticarea diabetului zaharat de tip 2 \u0219i la 5 ani dupa diagnosticarea diabetului zaharat de tip 1 \u2013 Standardul de ingrijire a diabetului din 2005 al Asociatiei Americane de Diabet (ADA).
\n\u2713 \u201eDoar 2% dintre pacientii cu diabet zaharat sunt testati pentru CAN, chiar daca acestia prezinta un risc deosebit de mare de complicatii cardiovasculare si moarte subita cardiaca.\u201d<\/p>\n

Cum functioneaza?<\/strong><\/p>\n

The device allows for quantitative assessment of sweat response (sympathetic skin response and sudomotor function) under mild electrical stimulation and in just 5-6 minutes, completely painlessly<\/strong>, specialists can detect polyneuropathy at its earliest stage. In patients suffering from metabolic imbalance and associated inflammatory processes, the thinnest nerve fibres of the sweat glands are damaged first. Testing is recommended for symptoms such as decreased sensitivity, numbness or pain in the extremities in patients with hypertension, overweight or patients diagnosed with diabetes. According to the American Diabetes Association clinical standards, this test should be performed immediately after diagnosis of type 2 diabetes and 5 years after diagnosis of type 1 diabetes.<\/p>\n

\"\"<\/strong><\/p>\n

Aplicatiile clinice ale noilor echipamente sunt \u00een domeniile endocrinologiei, neurologiei, cardiologiei, medicinii generale, managementului durerii; pentru screening-ul eficient al riscului cardiometabolic; \u00een polineuropatia periferica dureroasa cu teste negative de conducere nervoasa; in tulburari ale sistemului nervos autonom, secretiei sudoripare, sistemului cardiovascular si digestiv, hipertensiune arteriala etc.; in sindroame dureroase complexe; in neuropatia diabetica deja diagnosticata; in tulburari enzimatice; in RSD (distrofie simpatica reflexa); in distonia autonoma; pentru a evalua eficacitatea agentilor farmacologici.<\/p>\n

\"\"<\/strong><\/p>\n

Ce teste suplimentare putem face cu noul echipament?<\/strong><\/p>\n

\u2713 Neuropatie dureroasa a fibrelor fine cand rezultatele testelor de conducere nervoasa sunt normale;
\n\u2713 Tulburari ale sistemului nervos autonom, care controleaza glandele sudoripare, inima, sistemul digestiv, alte organe \u0219i tensiunea arteriala
\n\u2713 Sindroame dureroase complexe
\n\u2713 Neuropatii diabetice
\n\u2713 Tulburari enzimatice
\n\u2713 RSD (distrofie reflexa simpatica, sindrom de durere regionala complexa)
\n\u2713 Disautonomie
\n\u2713 Testarea produselor cosmetice \u0219i a medicamentelor
\n\u2713 Teste dermatologice
\n\u2713 Atrofie multipla a sistemului (sindromul Shy-Drager)<\/p>\n

Modulele analitice ofera rapoarte precise, cum ar fi apa extracelulara la cea intracelulara sau masa grasimii in greutate si prezinta medicilor informatii despre tulburarile care altfel ar necesita teste suplimentare pentru a diagnostica.<\/p>\n

Prezentarea grafica a rezultatelor este un alt avantaj. Ofera o imagine de ansamblu si ajuta la vizualizarea datelor.<\/p>\n

\"\"<\/p>\n

Pretul testului de raspuns simpatic al pielii: 100 LEVA. <\/strong><\/p>\n

Pentru mai multe informatii si rezervari: 064 678400<\/strong>[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][mk_fancy_title tag_name=”h4″ color=”#1e73be” size=”36″ force_font_size=”true” size_phone=”30″ txt_transform=”uppercase” font_family=”Open+Sans” font_type=”google” animation=”top-to-bottom”] Neuropatie periferica [\/mk_fancy_title][mk_padding_divider][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1663137609630{margin-bottom: 0px !important;}”]Spitalul pentru Inima si Creier are disponibile in clinica sa de neurologie echipamente pentru diagnosticarea precoce a polineuropatiei diabetice periferice \u2713 Conform studiilor clinice, \u201eNeuropatia autonoma cardiovasculara este observata la aproximativ 17% dintre pacien\u021bii cu diabet de tip 1 \u0219i […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":21732,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-26424","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/pages\/26424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/comments?post=26424"}],"version-history":[{"count":6,"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/pages\/26424\/revisions"}],"predecessor-version":[{"id":26430,"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/pages\/26424\/revisions\/26430"}],"up":[{"embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/pages\/21732"}],"wp:attachment":[{"href":"https:\/\/cardiacinstitute.bg\/ro\/wp-json\/wp\/v2\/media?parent=26424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}